Stoke Therapeutics, Inc. , a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicines, today announced the presentation of two-year data ...

Cha Bio Group said on the 21st that it recently held a forum at the Cha Bio Complex in Pangyo, Gyeonggi Province, to share the latest technology trends in cell and gene therapies (CGT). Cell and gene ...

Gene Simmons Paul Stanley and Peter Criss are paying tribute to their KISS co-founder Ace Frehley, who died at 74 on Thursday ...

Non-exclusive license for Solid Biosciences’ proprietary, next-generation myotropic capsid, AAV-SLB101, to accelerate development of KNA-155 for dysferlinopathy SEATTLE, September 23, 2025--(BUSINESS ...

A local gene therapy pioneer is taking on some of the rarest diseases known to medicine with a new venture spun out from his ...

In a deal that could bring more than $2.1 billion in payments to Arbor Biotechnologies Inc., 90-year-old Chiesi Group gained exclusive and global rights to develop and commercialize ABO-101 for ...

Kincell Bio Inc., a cell therapy contract development and manufacturing organization, today announced the signing of a memorandum of understanding with the Duke University School of Medicine. The ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Bio-Gene Technology ...

Opus Genetics Inc. will be sitting down with the U.S. FDA to talk about positive three-month data from the pediatric cohort of its ongoing phase I/II trial called OPGx-LCA5-1001 – partially funded by ...

Cancer diagnostics company GENCURIX said on the 2nd that it signed a strategic exclusive distribution agreement with Bio-Rad Laboratories, headquartered in California, to supply the digital PCR-based ...

From Game of Thrones’ Joffrey Baratheon to The Wire’s Marlo Stanfield, HBO has delivered some of television’s most iconic villains. TV is a great medium to develop a villain, because the audience has ...